## Abstract In this prospective study of 34 patients with Parkinson's disease, measurements of the short duration levodopa motor response have been performed in defined __off__ states at 3 yearly intervals over a mean period of 11.4 years from the point of commencement of levodopa treatment. Twenty
Modulatory effect of clozapine on levodopa response in parkinson's disease: A preliminary study
β Scribed by Gonzalo J. Gomez Arevalo; Dr. Oscar S. Gershanik
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 553 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Clozapine has been shown not only to be effective in ameliorating dopaminomimetic psychosis but to improve parkinsonian symptomatology. Six parkinsonian patients with motor fluctuations under levodopa treatment and severe interdose βoffβ periods (believed to be mediated by an inhibitory effect of subthreshold levels of levodopa) underwent a trial of clozapine. The effects of this drug on levodopa response were measured by means of an acute levodopa test both before and after receiving clozapine. After 1 month of treatment, clozapine 25 mg/day reduced parkinsonian scores at all stages of the evaluation (preβlevodopa βoff,β βon,β and interdose βoffβ). The effect was consistently more significant for the interdose βoff.β Clozapine could be exerting its beneficial effects through the inhibition of an inhibitory effect mediated by lowβlevel dopaminergic stimulation, thus behaving as an apparent antiparkinsonian drug.
π SIMILAR VOLUMES
## Abstract Patients suffering from Parkinson's disease (PD) frequently experienced painful sensations that could be in part due to central modification of nociception. We compared pain threshold before and after administration of levodopa in PD patients and in controls, and investigated cerebral a
Mood fluctuations related to levodopa (LD) dosing are well-known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing-off) and to different pharmacokinetic profiles of oral L
## Abstract While the beneficial effect of levodopa on traditional motor control tasks have been well documented over the decades, its effect on speech motor control has rarely been objectively examined and the existing literature remains inconclusive. This paper aims to examine the effect of levod